A carregar...
Berzosertib (VE-822) inhibits gastric cancer cell proliferation via base excision repair system
BACKGROUND: Current investigations suggest that the Base Excision Repair (BER) system may change DNA repair capacity and affect clinical gastric cancer progression such as overall survival. However, the prognostic value of BER system members in gastric cancer remains unclear. METHODS: We explored th...
Na minha lista:
| Publicado no: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6750847/ https://ncbi.nlm.nih.gov/pubmed/31571995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S217375 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|